ABO-incompatible kidney transplantation using both A2 and non-A2 living donors

Transplantation

Volumn 75, Issue 7, 2003, Pages 971-977

  Gloor, James M ^a   Lager, Donna J ^a   Moore, S Breanndan ^a   Pineda, Alvaro A ^a   Fidler, Mary E ^a   Larson, Timothy S ^a   Grande, Joseph P ^a   Schwab, Thomas R ^a   Griffin, Matthew D ^a   Prieto, Mikel ^a   Nyberg, Scott L ^a   Velosa, Jorge A ^a   Textor, Steven C ^a   Platt, Jeffrey L ^a   Stegall, Mark D ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ANTIBODY TITER; ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FOLLOW UP; GLOMERULUS FILTRATION RATE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HYPERACUTE GRAFT REJECTION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LIVING DONOR; PLASMAPHERESIS; PRIORITY JOURNAL; SPLENECTOMY; SURVIVAL RATE; SURVIVAL TIME;

EID: 10744227354     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000058226.39732.32     Document Type: Article

References (24)

1. 2000 Annual Report of the U.S. Scientific Registry for Transplant Recipients and the Organ Procurement and Transplantation Network: Transplant data: 1990-1999. Rockville, MD, Richmond, VA: U.S. Department of Health and Human Services, Health Resources and Services Administration, Office of Special Programs, Division of Transplantation, United Network for Organ Sharing 2000.
2. Montgomery RA, Zachary AA, Racusen LC, et al. Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients. Transplantation 2000; 70(6): 887.
3. Schweitzer E, Wilson JS, Fernandez-Vina M, et al. A high panel-reactive antibody rescue protocol for cross-match-positive live donor kidney transplants. Transplantation 2000; 70(10): 1531.
4. Tyan D, Li V, Czer L, et al. Intravenous immunoglobulin suppression of HLA alloantibody in highly sensitized transplant candidates and transplantation with a histoincompatible organ. Transplantation 1994; 57(4): 553.
5. Glotz D, Antoine C, Julia P, et al. Desensitization and subsequent kidney transplantation of patients using intravenous immunoglobulin. Am J Transplant 2002; 2: 758.
6. Starzl TE, Marchioro TL, Holmes JH, et al. Renal homografts in patients with major donor-recipient blood group incompatibilities. Surgery 1964; 55:195-200.
7. Cook DJ, Graver B, Terasaki PI. ABO incompatibility in cadaver donor kidney allografts. Transplant Proc 1987; 19(6): 4549.
8. Bannett AD, McAleck RF, Raja R, et al. Experiences with known ABO-mismatched renal transplants. Transplant Proc 1987; 19(6): 4543.
9. Schonitzer D, Niederwieser D, Aulitzky W, et al. ABO-incompatible renal transplantation: Report of two transplants from AB donors to A recipients. Transplant Proc 1987; 19(6): 4547.
10. Chopek MW, Simmons RL, Platt JL. ABO-incompatible kidney transplantation: Initial immunologic evaluation. Transplant Proc 1987; 19(6): 4553.
11. Raja R, McAleck R, Mendez M, et al. Technical aspects of antibody immunoadsorption prior to ABO-incompatible renal transplant. Transplant Proc 1987; 19(6): 4525.
12. Alexandre GPJ, Squifflet JP, De Bruyere M, et al. Present experience in a series of 26 ABO-incompatible living donor renal allografts. Transplant Proc 1987; 19(6): 4538.
13. Slapak M, Digard N, Ahmed M, et al. Renal transplantation across the ABO barrier: A 9 year experience. Transplant Proc 1990; 22(4): 1425.
14. Clausen H, Levery SB, Nudelman E, et al. Repetitive A epitope (type 3 chain A) defined by blood group A1-specific monoclonal antibody TH-1: Chemical basis of qualitative A1 and A2 distinction. Immunology 1985; 82: 1199.
15. Breimer ME, Brynger H, Samuelsson BE. Transplantation of blood group A2 kidneys to O recipients: Biochemical and immunological studies of blood group A antigens in human kidneys. Transplant Proc 1985; 17(6): 2640.
16. Tanabe K, Takahashi K, Sonda K, et al. Long-term results of ABO-incompatible living kidney transplantation. Transplantation 1998; 65: 224.
17. Vengelen-Tyler V. Technical manual [ed 13]. Bethesda, MD, American Association of Blood Banks 1999.
18. Nelson PW, Landreneau MD, Luger AM, et al. Ten-year experience in transplantation of A2 kidneys into B and O recipients. Transplantation 1998; 65(2): 256.
19. Alkhunaizi AH, De Mattos AM, Barry JM, et al. Renal transplantation across the ABO barrier using A2 kidneys. Transplantation 1999; 67(10): 1319.
20. Sorensen JB, Grant WJ, Belnap LP, et al. Transplantation of ABO group A2 kidneys from living donors into group O and B recipients. Am J Transplant 2001; 1: 296.
21. Shimmura H, Tanabe K, Ishikawa N, et al. Role of anti-A/B antibody titers in results of ABO-incompatible kidney transplantation. Transplantation 2000; 70: 1331.
22. Alexandre GPJ, Squiffiet JP, De Bruyere M, et al. Splenectomy as a prerequisite for successful human ABO-incompatible renal transplantation. Transplant Proc 1985; 17(1): 138.
23. Mauiyyedi S, Crespo M, Collins AB, et al. Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification. J Am Soc Nephrol 2002; 13: 779.
24. Onitsuka S, Yamaguchi Y, Tanabe K, et al. Peritubular capillary deposition of C4d complement fragment in ABO-incompatible renal transplantation with humoral rejection. Clin Transplant 1999; 13 (suppl 1): 33.